Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan:57-58:299-310.
doi: 10.1016/j.matbio.2016.09.002. Epub 2016 Sep 6.

Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation

Dorin-Bogdan Borza  1
Affiliations
Review

Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation

Dorin-Bogdan Borza. Matrix Biol. 2017 Jan.

Abstract

The glomerular basement membrane (GBM) is an essential component of the glomerular filtration barrier. Heparan sulfate proteoglycans such as agrin are major components of the GBM, along with α345(IV) collagen, laminin-521 and nidogen. A loss of GBM heparan sulfate chains is associated with proteinuria in several glomerular diseases and may contribute to the underlying pathology. As the major determinants of the anionic charge of the GBM, heparan sulfate chains have been thought to impart charge selectivity to the glomerular filtration, a view challenged by the negligible albuminuria in mice that lack heparan sulfate in the GBM. Recent studies provide increasing evidence that heparan sulfate chains modulate local complement activation by recruiting complement regulatory protein factor H, the major inhibitor of the alternative pathway in plasma. Factor H selectively inactivates C3b bound to surfaces bearing host-specific polyanions such as heparan sulfate, thus limiting complement activation on self surfaces such as the GBM, which are not protected by cell-bound complement regulators. We discuss mechanisms whereby the acquired loss of GBM heparan sulfate can impair the local regulation of the alternative pathway, exacerbating complement activation and glomerular injury in immune-mediated kidney diseases such as membranous nephropathy and lupus nephritis.

Keywords: Alternative pathway; Complement; Factor H; Glomerular basement membrane; Heparan sulfate.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of the complement activation cascade
Complement activation is initiated by three pathways (green), converging toward activation of C3, which is further amplified in a positive feed-back loop (blue). The terminal complement pathway (purple) is activated upon the formation of C5 convertases that cleave C5. The underlined components attach covalently to target.
Figure 2
Figure 2. Factor H structure and function
A. Domain organization of factor H and the location of functional sites. B. Factor H inhibits the alternative pathway by several mechanisms: (a) inhibiting the binding of factor B to C3b, (b) accelerating the decay of the C3bBb convertase, and (c) serving as cofactor for factor I (fI), which inactivates C3b to iC3b. The ability of factor H to inhibit complement amplification on self surfaces (depicted as horizontal lines) is contingent upon its recognition of host-specific polyanions, such as heparan sulfate (HS).
Figure 3
Figure 3. GBM heparan sulfate modulates local complement activation
(A.) Heparan sulfate (HS), abundant in the normal GBM, helps recruit factor H to locally inactivate GBM-bound C3b (right). In the absence of GBM heparan sulfate, this regulation is ineffective, allowing local amplification of complement activation (left). (B.) In kidney diseases mediated by glomerular immune complexes, the acquired loss of GBM heparan sulfate chains impairs the recruitment of factor H and the local complement regulation, thereby creating a vicious cycle (shown in red), which amplifies complement activation and exacerbates glomerular injury.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abrahamson DR, Hudson BG, Stroganova L, Borza DB, St John PL. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol. 2009;20(7):1471–9. - PMC - PubMed
    1. St John PL, Abrahamson DR. Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int. 2001;60(3):1037–46. - PubMed
    1. Miner JH. Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol. 2011;26(9):1413–7. - PMC - PubMed
    1. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248(4960):1224–7. - PubMed
    1. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nature genetics. 1994;8(1):77–81. - PubMed

Publication types

MeSH terms

LinkOut - more resources